Home Stock

Stock Research: Kaken Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Kaken Pharmaceutical

TYO:4521 JP3207000005
78
  • Value
    73
  • Growth
    65
  • Safety
    Safety
    92
  • Combined
    92
  • Sentiment
    26
  • 360° View
    360° View
    78
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

KAKEN PHARMACEUTICAL CO., LTD. is a Japan-based company producing and selling pharmaceutical products. The company operates in the Pharmaceutical segment (manufacturing and sale of pharmaceuticals, medical devices, and agricultural drugs) and the Real Estate segment (leasing real estate). It is based in Japan. In the last fiscal year, the company had a market cap of $1133 million, profits of $390 million, revenue of $627 million, and 1126 employees.

more

ANALYSIS: With an Obermatt 360° View of 78 (better than 78% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Kaken Pharmaceutical are very positive. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators above average for Kaken Pharmaceutical. The consolidated Value Rank has an attractive rank of 73, which means that the share price of Kaken Pharmaceutical is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 73% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 65, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. The company is also safely financed with a Safety Rank of 92. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of only 26. Professional investors are more confident in 74% other stocks. ...read more

more
Strongest Rank Capital Growth
Weakest Rank Dividend Yield
Country Japan
Industry Pharmaceuticals
Size Medium
Website kaken.co.jp
Index
Kaken Pharmaceutical stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Aug-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
73 48 84 75
Growth
65 63 5 35
Safety
Safety
92 84 94 96
Sentiment
26 20 12 8
360° View
360° View
78 58 42 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
15 28 22 7
Opinions Change
50 50 50 50
Pro Holdings
n/a 52 10 57
Market Pulse
28 22 16 7
Sentiment
26 20 12 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
73 48 84 75
Growth
65 63 5 35
Safety Safety
92 84 94 96
Combined
92 81 71 88
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
40 33 53 41
Price vs. Earnings (P/E)
59 24 60 86
Price vs. Book (P/B)
74 74 86 71
Dividend Yield
100 82 94 94
Value
73 48 84 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
39 1 11 11
Profit Growth
100 75 25 38
Capital Growth
11 61 35 48
Stock Returns
72 90 29 79
Growth
65 63 5 35
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
89 75 77 74
Refinancing
34 78 91 81
Liquidity
94 79 86 90
Safety Safety
92 84 94 96

Similar Stocks

Discover high‑ranked alternatives to Kaken Pharmaceutical and broaden your portfolio horizons.

Mitsubishi Materials

TYO:5711
Country: Japan
Industry: Diversified Metals & Mining
Size: X-Large
Full Stock Analysis

Megmilk Snow Brand

TYO:2270
Country: Japan
Industry: Packaged Foods & Meats
Size: Large
Full Stock Analysis

Kansai Electric Power

TYO:9503
Country: Japan
Industry: Electric Utilities
Size: Large
Full Stock Analysis

Resorttrust

TYO:4681
Country: Japan
Industry: Hotels, Resorts & Cruise Lines
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock has excellent financial qualities (value, growth, and safety are high) but a negative professional market sentiment. It suits an investor who believes the negative sentiment is a temporary overreaction and is looking for a financially solid company.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews